Cargando…

Targeting Csnk1a1 in leukemia

Detalles Bibliográficos
Autor principal:	Stegmaier, Kimberly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2014
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978273/ https://www.ncbi.nlm.nih.gov/pubmed/24711612 http://dx.doi.org/10.1084/jem.2114insight1

Ejemplares similares

Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
por: Järås, Marcus, et al.
Publicado: (2014)

Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases
por: Unni, Prasida, et al.
Publicado: (2022)

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

Prognostic value and immunological role of CSNK1D in human cancers
por: Wang, Jianguo, et al.
Publicado: (2023)

CSNK2 in cancer: pathophysiology and translational applications
por: Strum, Scott W., et al.
Publicado: (2021)

Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022)

Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma
por: Liu, Guanzheng, et al.
Publicado: (2021)

Compartmentalization of casein kinase 1 γ CSNK1G controls the intracellular trafficking of ceramide
por: Goto, Asako, et al.
Publicado: (2022)

Circular RNA CSNK1G1 promotes the progression of osteoarthritis by targeting the miR-4428/FUT2 axis
por: Xiao, Jianwei, et al.
Publicado: (2021)

Circular RNA CSNK1G1 promotes the progression of osteoarthritis by targeting the miR-4428/FUT2 axis
por: Xiao, Jianwei, et al.
Publicado: (2022)

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
por: Bello, Erica, et al.
Publicado: (2015)

Effective double whammy targets DNA synthesis in leukemia
por: Chabner, Bruce A.
Publicado: (2014)

CSNK1E/CTNNB1 Are Synthetic Lethal To TP53 in Colorectal Cancer and Are Markers for Prognosis
por: Tiong, Khong-Loon, et al.
Publicado: (2014)

Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses
por: Yang, Xuan, et al.
Publicado: (2022)

CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer
por: Shi, Zhan, et al.
Publicado: (2021)

CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression
por: Yang, Bing, et al.
Publicado: (2023)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
por: Yang, Cui-Ping, et al.
Publicado: (2018)

PS162. Genetic role of CSNK1E on circadian and childhood characteristics of the patients with major depressive disorder
por: Joo, Eun-Jeong, et al.
Publicado: (2016)

Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Leukemia-specific delivery of mutant NOTCH1 targeted therapy
por: Roti, Giovanni, et al.
Publicado: (2018)

Germline de novo variants in CSNK2B in Chinese patients with epilepsy
por: Li, Jinliang, et al.
Publicado: (2019)

lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level
por: Nie, Zhenlin, et al.
Publicado: (2023)

CSNK1G2-AS1 promotes metastasis, colony formation and serves as a biomarker in testicular germ cell tumor cells
por: Li, Ruixue, et al.
Publicado: (2023)

Why isn’t the angiotensin type 1 receptor a target in cancer?
por: Vinson, Gavin P.
Publicado: (2017)

CircCSNK1G1 Contributes to the Development of Colorectal Cancer by Increasing the Expression of MYO6 via Competitively Targeting miR-455-3p
por: Huang, Xianming, et al.
Publicado: (2020)

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2
por: Yang, Xuan, et al.
Publicado: (2022)

CircCSNK1G1 Contributes to the Tumorigenesis of Gastric Cancer by Sponging miR-758 and Regulating ZNF217 Expression
por: Qiang, Feng, et al.
Publicado: (2021)

circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment
por: Piras, Roberta, et al.
Publicado: (2022)

Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2
por: Torii, Satoru, et al.
Publicado: (2023)

Gadd45 stress sensors in suppression of leukemia
por: Wiest, David L.
Publicado: (2018)

Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion
por: Stalmann, Ursula S. A., et al.
Publicado: (2022)

Author Correction: Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
por: Yang, Cui-Ping, et al.
Publicado: (2018)

CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling
por: Matsumoto, Moe, et al.
Publicado: (2023)

Long non-coding RNA B3GALT5-AS1 contributes to the progression of gastric cancer via interacting with CSNK2A1
por: Wang, Ping, et al.
Publicado: (2021)

CANCER: Childhood Leukemia and Proximity to Nuclear Power Plants
por: Burton, Adrian
Publicado: (2009)

Major progress in understanding progression in chronic myeloid leukemia
por: Radich, Jerry
Publicado: (2015)

Dual roles of EZH2 in acute myeloid leukemia
por: Skoda, Radek C., et al.
Publicado: (2019)

CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
por: Jiang, Chao, et al.
Publicado: (2019)

CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling
por: Yu, Shijun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fessvcuocv1gmo9d5ov7s4didh